Press releases

Vidi-grants for Elisabetta Citterio and Karin de Visser

Last week two young, talented NKI-AVL researchers received a Vidi-grant from the Netherlands Organisation for Scientific Research (NWO).

Discovery of several hundreds of potential cancer genes

Researchers have found over 250 new genes that are potentially involved in the development of leukemia.

A novel family of antibiotics

Researchers have discovered new ways to fight bacterial infections including extensively drug-resistant tuberculosis. The work will be published in the journal Nature on 29 November.

EMBO welcomes fifty leading scientists

Top cancer grant to NKI-AvL researcher Daniel Peeper

NKI-AVL researcher dr. Daniel Peeper has been awarded a top grant of two million euros by the Dutch Cancer Society (KWF).

p15 critical tumour suppressor in absence of p16

Scientist at the Netherlands Cancer Institute – Antoni Van Leeuwenhoek Hospital in Amsterdam have discovered that p15 can fulfil a critical backup function for p16 and provide an explanation for the frequent loss of p16, p19 and p15 in human tumours.

In biology polarization is a good thing

How inflammatory proteins can protect against cancer

EMBO honours Daniel Peeper and Bas van Steensel as leading life scientists

Recognition of their proven excellence in research.

European Comprehensive Cancer Centre Alliance (ECCCA)

Three leading European Cancer Comprehensive Centres launch an international cooperation at top level.

New tumor inhibitor for treatment of hereditary breast cancer shows promising results

Sven Rottenberg, Piet Borst and Jos Jonkers publish the results of their study in a mouse model this week in PNAS Online Early Edition.